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Abstract. 
 
To gain insight into the regeneration deficit 
 
of 
 
MyoD
 
2
 
/
 
2
 
 muscle, we investigated the growth and 
differentiation of cultured 
 
MyoD
 
2
 
/
 
2
 
 myogenic cells. 
Primary 
 
MyoD
 
2
 
/
 
2
 
 myogenic cells exhibited a stellate 
morphology distinct from the compact morphology of 
wild-type myoblasts, and expressed c-met, a receptor 
tyrosine kinase expressed in satellite cells. However, 
 
MyoD
 
2
 
/
 
2
 
 myogenic cells did not express desmin, an 
intermediate filament protein typically expressed in 
cultured myoblasts in vitro and myogenic precursor 
cells in vivo. Northern analysis indicated that proliferat-
ing 
 
MyoD
 
2
 
/
 
2
 
 myogenic cells expressed fourfold 
higher levels of 
 
Myf-5
 
 and sixfold higher levels of 
 
PEA3
 
, an ETS-domain transcription factor expressed 
in newly activated satellite cells. Under conditions that 
 
normally induce differentiation, 
 
MyoD
 
2
 
/
 
2
 
 cells con-
tinued to proliferate and with delayed kinetics yielded 
reduced numbers of predominantly mononuclear myo-
cytes. Northern analysis revealed delayed induction of 
 
myogenin
 
, 
 
MRF4
 
, and other differentiation-specific 
markers although 
 
p21
 
 was upregulated normally. Ex-
pression of 
 
M-cadherin
 
 mRNA was severely decreased 
whereas expression of 
 
IGF-1
 
 was markedly increased in 
 
MyoD
 
2
 
/
 
2
 
 myogenic cells. Mixing of lacZ-labeled 
 
MyoD
 
2
 
/
 
2
 
 cells and wild-type myoblasts revealed a 
strict autonomy in differentiation potential. Transfec-
tion of a 
 
MyoD
 
-expression cassette restored cytomor-
phology and rescued the differentiation deficit. We in-
terpret these data to suggest that 
 
MyoD
 
2
 
/
 
2
 
 myogenic 
cells represent an intermediate stage between a quies-
cent satellite cell and a myogenic precursor cell.
Key words: MyoD ¥ myogenic regulatory factor ¥ sat-
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1. 
 
Abbreviations used in this paper:
 
 BrdU, 5-bromo-2
 
9
 
-deoxyuridine; MHC,
myosin heavy chain; MRF, myogenic regulatory factors.
 
T
 
HE
 
 myogenic regulatory factors (MRFs)
 
1
 
 form a
group of four basic helix-loop-helix transcription
factors consisting of MyoD, Myf-5, myogenin, and
MRF4. The MRFs have been demonstrated to play pivotal
roles in the determination and differentiation of myogenic
precursors into mature skeletal muscle (Weintraub et al.,
1991; Rudnicki and Jaenisch, 1995). Gene targeting exper-
iments have provided much insight into understanding
MRF function in vivo. The introduction of null mutations
in all four factors into the germline of mice has revealed
the existence of a hierarchical relationship among the
MRFs and has defined two functional groups of MRFs
(Braun et al., 1992; Rudnicki et al., 1992, 1993; Nabeshima
et al., 1993; Patapoutian et al., 1995; Zhang et al., 1995).
The primary MRFs, MyoD and Myf-5, appear to be re-
quired for myogenic determination, whereas the second-
ary MRFs, myogenin and MRF4, are required later in the
developmental program as differentiation factors (Me-
geney and Rudnicki, 1995; Rudnicki and Jaenisch, 1995).
Satellite cells, the stem cells of adult skeletal muscle, re-
side beneath the basal lamina of adult skeletal muscle
closely juxtaposed against muscle fibers. Satellite cells
arise around day 17 of development and are believed to
represent a unique myoblast lineage distinct from embry-
onic and fetal lineages (Cossu et al., 1985; Bischoff, 1994).
Satellite cells make up 2Ð7% of the nuclei associated with
a particular fiber and the proportion varies with age and
particular muscle group. Satellite cells are normally mitot-
ically quiescent, but are activated (i.e., initiate multiple
rounds of proliferation) in response to stress induced by
weight bearing or other trauma such as injury. The descen-
dants of the activated satellite cells, myogenic precursor
cells, undergo multiple rounds of division prior to fusing to
existing or new fibers. Satellite cells appear to form a pop-
ulation of stem cells that are distinct from their daughter
 
myogenic precursor cells as defined by biological and
biochemical criteria (Bischoff, 1994). The total number of
satellite cells in muscle remains relatively constant, sug-
gesting that a capacity for self-renewal in the satellite cell
compartment maintains the population of quiescent cells
(Bischoff, 1994). 
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Quiescent satellite cells express no detectable MRFs.
Upon activation and entrance into the cell cycle, MyoD is
rapidly upregulated concomitantly with proliferating cell
nuclear antigen, a marker for cell proliferation, whereas
myogenin is expressed last during the time associated with
fusion and differentiation (Smith et al., 1994; Yablonka-
Reuveni and Rivera, 1994). Analysis of gene expression by
RT-PCR of individual satellite cells in cultured intact mus-
cle fibers at times after their activation substantiates that
quiescent satellite cells express no detectable MRFs but
do express 
 
c-met
 
, a receptor tyrosine kinase (Cornelison
and Wold, 1997). Moreover, these experiments reveal that
activated satellite cells first express either 
 
Myf-5
 
 or 
 
MyoD
 
followed soon after by coexpression of 
 
Myf-5
 
 and 
 
MyoD.
 
After proliferation, 
 
myogenin
 
 and 
 
MRF4
 
 are expressed in
cells beginning their differentiation program (Cornelison
and Wold, 1997).
The regeneration deficit observed in 
 
MyoD
 
2
 
/
 
2
 
 muscle
strongly supports the assertion that MyoD plays an essen-
tial role in regulating the satellite cell myogenic program
(Megeney et al., 1996). Muscle regeneration is severely de-
ficient in 
 
MyoD
 
2
 
/
 
2
 
 mice and compound mutant mice
lacking both 
 
MyoD
 
 and 
 
dystrophin
 
 (designated 
 
mdx:
MyoD
 
2
 
/
 
2
 
) exhibit severe myopathy leading to premature
death (Megeney et al., 1996). Muscle regeneration in
 
MyoD
 
2
 
/
 
2
 
 muscle is characterized by an almost complete
absence of proliferative myogenic precursor cells. How-
ever, electron microscopic examination of 
 
MyoD
 
-deficient
muscle reveals increased numbers of satellite cells and the
number of primary myoblasts recovered is increased 2.5-
fold in 
 
MyoD
 
2
 
/
 
2
 
 muscle and 13-fold in 
 
mdx:MyoD
 
2
 
/
 
2
 
muscle. Taken together, our data suggest a model in which
upregulation of 
 
MyoD
 
 is required for satellite cells to en-
ter the myogenic precursor cell proliferative phase that
precedes terminal differentiation. In the absence of 
 
MyoD
 
,
myogenic stem cells undergo an apparent increase in num-
bers as a consequence of an increased propensity for self-
renewal rather than progression through the myogenic dif-
ferentiation program (Megeney et al., 1996).
To investigate the function of 
 
MyoD
 
 during the course
of satellite cell activation, we established primary myo-
genic cultures from wild-type and 
 
MyoD
 
-deficient adult
muscle. Importantly, these experiments were performed
with newly established low-passage primary cultures. Our
analysis strongly supports the hypothesis that 
 
MyoD 
 
is re-
quired for satellite cells to progress efficiently through the
myogenic precursor cell developmental program. More-
over, our data suggest that 
 
MyoD
 
2
 
/
 
2
 
 myogenic cells rep-
resent an intermediate developmental stage between qui-
escent satellite cells and myogenic precursor cells.
 
Materials and Methods
 
Isolation of Primary Myoblasts, Cell Culture,
and Immunohistochemistry
 
Satellite cellÐderived primary myoblasts were isolated from adult lower
hindlimb muscle from 2Ð3-mo-old mice as described previously (Megeney
et al., 1996), with the exception that hepatocyte growth factor (10 ng/ml;
R&D Systems Inc.) and heparin (5 ng/ml; Sigma Chemical Co.) were in-
cluded in the growth medium for the first 48 h after the plating of the final
cell preparation, and supplemented with FGF2 (2.5 ng/ml FGF2) thereaf-
ter. The primary cultures were maintained on collagen-coated dishes in
 
HamÕs F10 (GIBCO BRL) supplemented with 20% FCS, 200 U/ml penicil-
lin, 200 
 
m
 
g/ml streptomycin, and 0.002% Fungizone (GIBCO BRL). The
medium was changed daily and cultures were routinely passaged 1:3 as
they reached 60Ð70% confluence. To maintain the primary characteristics
of the cells, all experiments were performed using cultures that had under-
gone between four and seven passages. Differentiation medium consisted
of DME supplemented with 5% horse serum and antibiotics as described
above (GIBCO BRL).
The extent of culture purity and differentiation was determined by sub-
jecting the purified myoblasts to c-met, desmin, and myosin heavy chain
(MHC) immunostaining. Briefly, myoblasts in growth medium were fixed
in 4% paraformaldehyde in PBS (PFA), stained with antiÐc-met antibody
SP260 (Santa Cruz Biotechnology), and antidesmin antibody DE-U-10
(DAKO). MHC expression was detected by fixing differentiated cultures
with 90% methanol and staining with MF20 mAb (Bader et al., 1982). Im-
munostaining was similarly performed with antiÐ
 
b
 
-catenin antibody sc-
1496 (Santa Cruz Biotechnology) and antiÐM-cadherin antibody sc-6470
(Santa Cruz Biotechnology). Immunostaining with antiÐc-met and antiÐ
 
b
 
-catenin antibodies were detected with fluorescein-conjugated antiÐgoat
antibodies (Sigma Chemical Co.), and photographed on a Zeiss Axiophot
microscope equipped with a UV source and FITC detection filters.
Desmin, M-cadherin, and MHC staining was visualized using a HRP-cou-
pled secondary antibody (Bio-Rad Laboratories) in PBS containing 0.6
mg/ml diaminobezidine (Sigma Chemical Co.).
 
Differentiation Time Course and Growth
Rate Measurements
 
Growth rate analysis was determined by [
 
3
 
H]thymidine incorporation of
three independent isolates of wild-type and 
 
MyoD
 
2
 
/
 
2
 
 cultures seeded in
24-well plates at 10
 
4
 
 cells per well in growth medium (each in triplicate).
For day 0, the cells were cultured 24 h in growth medium before addition
of 2 
 
m
 
Ci of [
 
3
 
H]thymidine for 2 h. Incorporation of [
 
3
 
H]thymidine was
normalized to protein concentration as determined by Bradford assay.
The remaining wells were exposed to differentiation medium and labeled
with [
 
3
 
H]thymidine for 2 h on sequential days.
To assay the differentiation potential of wild-type and 
 
MyoD
 
2
 
/
 
2
 
 cul-
tures, 10
 
5
 
 low passage cells were seeded into 35-mm dishes in growth me-
dium and cultured for an additional 24 h (day 0) before addition of differ-
entiation medium. On subsequent days (1Ð5), the cultures were fixed and
immunostained for MHC with antibody MF20. To establish the differenti-
ation potential of the cultures, at least 1,000 nuclei from MF20-positive
cells were counted from several random fields. The percentage of differ-
entiated cells was calculated as: (
 
nuclei within MF20-stained myocytes
 
/
 
total
number of nuclei
 
) 
 
3
 
 100; or the fusion index calculated as: (
 
MF20-stained
myocytes containing 
 
$
 
2 
 
nuclei/total number of nuclei
 
) 
 
3
 
 100. 5-bromo-
2
 
9
 
-deoxyuridine (BrdU) incorporation assays on cultured cells were per-
formed (cell proliferation kit; Amersham Pharmacia Biotech). All experi-
ments were performed in triplicate on three independent wild-type and
 
MyoD
 
2
 
/
 
2
 
 isolates.
 
Northern and Western Analysis
 
To analyze the expression of the MRFs and of differentiation-specific
markers, total RNA from low passage cells in growth (day 0) or differenti-
ation medium (days 1Ð5) was isolated (Birnboim, 1988) and subjected to
Northern analysis (Maniatis et al., 1982). Replicate filters were sequen-
tially hybridized to MRF-specific cDNAs as well as 
 
a
 
-cardiac and 
 
a
 
-skele-
tal actin, and acetylcholine receptor 
 
d
 
 subunit probes (Rudnicki et al.,
1993). Dr. Paul Hastings (McGill University) kindly provided the M-cad-
herin probe. The 
 
Musk
 
 cDNA probe was obtained by RT-PCR of C2C12
RNA. The 
 
b
 
-
 
catenin
 
 and 
 
PEA3
 
 probes were kindly provided by Drs. Rolf
Kemler (Max Planck Institute) and John A. Hassell (McMaster Univer-
sity), respectively. Western analysis with rabbit antiÐMyf-5 antibody C-20
(Santa Cruz Biotechnology), mouse anti-MyoD antibody 5A8 (PharMin-
gen), and mouse antimyogenin antibody F5D (Developmental Studies
Hybridoma Bank) was performed on extracts prepared from cultures in
growth medium as described previously (LeCouter et al., 1996).
 
Mixing of LacZ-expressing MyoD
 
2
 
/
 
2
 
 and
Wild-Type Cultures
 
Early passage 
 
MyoD
 
2
 
/
 
2
 
 cultures were lipofected with a 1:10 ratio of
PGK-LacZ-MAR and PGK-Puro plasmids, and stable transformants were
pooled after 10 d of selection in 2 
 
m
 
g/ml puromycin. Plasmid PGK-LacZ- 
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MAR contains the phosphoglycerate kinase 1 promoter expressing nls-
lacZ and a chicken lysozyme matrix attachment region to confer high level
site-independent expression (Phi-Van and Stratling, 1996). Primary cells
were plated with an initial density of 10
 
5
 
 cells per 60-mm well, in ratios of
1:0, 1:4, 4:1, and 0:1 of 
 
MyoD
 
2
 
/
 
2
 
 to wild-type cells. Duplicate cultures
were grown overnight in growth medium before exposing to differentia-
tion medium for 5 d. Wells were washed with PBS, fixed in 2% formalde-
hyde/0.4% glutaraldehyde followed by X-Gal staining. Cells were post-
fixed with 90% methanol for 7 min, rinsed with PBS and 0.3% Triton X,
before immunostaining with antibody MF-20 as described above.
 
Transfection with MyoD Plasmid and Generation of 
Stable MyoD
 
1
 
 Pools
 
Low passage subconfluent cultures of MyoD2/2 cells were transfected
with pEMSV-MyoD/PGK-Puro or PGK-Puro alone by lipofectamine
(GIBCO BRL), according to the manufacturerÕs instructions. The MyoD
expression plasmid carries the murine MyoD cDNA driven by the EMSV
promoter and enhancer, as well as a puromycin resistance cassette. The
cultures were refed 24 h after transfection and daily with growth medium
containing 2 mg/ml puromycin (Sigma Chemical Co.) for 10 d. The result-
ing colonies (.200) were pooled and expanded for further analysis. MyoD
expression was evaluated by Western blot analysis (LeCouter et al., 1996)
using anti-MyoD mAb 5A8 (PharMingen). The differentiation and fusion
potentials of MyoD-expressing pools were assayed as described above.
Results
Altered Cellular Phenotype of MyoD2/2
Myogenic Cells
To gain insight into the role of MyoD in satellite cell acti-
vation, low passage primary cultures were isolated from
2Ð3-mo-old wild-type and MyoD2/2 mice to facilitate the
generation of highly purified satellite cellÐderived cultures
and preclude the inclusion of neonatal myoblasts. Cultures
were grown for 48 h in the presence of hepatocyte growth
factor and thereafter in medium supplemented with FGF2
to allow the rapid recovery of high numbers of low passage
primary myoblasts as described previously (Allen et al.,
1995).
As suggested by our previous observations (Megeney
et al., 1996), MyoD2/2 cultures displayed a stellate flat-
tened morphology with an enlarged cytoplasm and ex-
tended cytosolic processes. By contrast, wild-type cells
were highly refractile under phase-contrast microscopy
and displayed the rounded morphology and small compact
cytoplasm characteristic of primary myoblasts (see Figs. 1
and 8).
Quiescent and activated satellite cells in vivo express the
receptor tyrosine kinase c-met as do cultured myoblasts
(Allen et al., 1995; Cornelison and Wold, 1997). Proliferat-
ing myogenic precursor cells in vivo and myoblasts in vitro
express the intermediate filament desmin. However, satel-
lite cells do not express desmin (George-Weinstein et al.,
1993). Therefore, primary cultures were immunostained
with antibody reactive with c-met and desmin to assess
their developmental status. Virtually 100% of the primary
cells derived from both wild-type and MyoD2/2 animals
expressed high levels of c-met as detected by indirect im-
munofluorescence. Fibroblast cell lines did not express
c-met (not shown). Therefore, the isolation procedure
generated highly purified cultures of myogenic cells (Fig. 1
a). In contrast to the uniform expression of c-met, only
6.2 6 5.4% of MyoD2/2 myogenic cells expressed the
myoblast marker desmin, whereas 89 6 4.2% of wild-type
cells expressed desmin (Fig. 1 b). These data are consistent
with the notion that MyoD2/2 myogenic cells represent
an intermediate developmental stage between a satellite
cell and myogenic precursor cells.
Reduced Differentiation Potential of MyoD2/2 
Myogenic Cultures
To evaluate the differentiation potential of the MyoD2/2
myogenic cultures the extent of myogenic differentiation
was assessed at the cellular level by immunostaining cul-
tures fixed at daily intervals after mitogen withdrawal with
antibody MF20 reactive with MHC (Fig. 2 a). Importantly,
this analysis was performed on three independently iso-
lated wild-type and MyoD2/2 primary myogenic cultures.
After MF20 immunostaining, the proportion of MHC-pos-
itive cells and the fusion index of both wild-type and
MyoD2/2 cultures were assessed (Fig. 2, b and c).
Under growth conditions, MyoD2/2 myogenic cells ex-
hibited about a 100-fold reduction in the rate of spontane-
ous differentiation (0.10 6 0.14%) compared to wild-type
Figure 1. Primary MyoD2/2 myogenic cells exhibit a premyo-
blastic cellular phenotype. (a) Immunostaining revealed that
both wild-type (Wildtype) and MyoD-deficient myogenic cells
(MyoD2/2) expressed the c-met receptor tyrosine kinase, a
marker for satellite cells and proliferating myoblasts. (b) Immu-
nohistochemical analysis for desmin expression revealed a
marked reduction in the proportion of cells in MyoD2/2 cul-
tures expressed desmin relative to wild-type cultures. (c) Normal
level and localization of b-catenin in MyoD2/2 cells as revealed
by immunofluorescence. (d) Immunohistochemical detection of
M-cadherin revealed low level expression of M-cadherin in
MyoD2/2 cells relative to primary wild-type myoblasts.The Journal of Cell Biology, Volume 144, 1999 634
cells (10 6 1.4%) (see day 0 in Fig. 2, a and b). Consistent
with this observation, MyoD2/2 cultures displayed a se-
vere defect in their ability to differentiate and form multi-
nucleated myotubes after mitogen withdrawal (Fig. 2 a).
Differentiated wild-type myocytes displayed the typical
elongated and multinucleated morphology, whereas dif-
ferentiated MyoD2/2 myocytes were primarily mononu-
clear and retained a fibroblastic stellate cytomorphology
(Fig. 2 a).
About 50% of the cells in wild-type cultures after 24 h in
differentiation medium had begun to undergo terminal
differentiation as assessed by MHC immunostaining (Fig.
2, a and b). The number of differentiated wild-type myo-
cytes continued to accumulate in a linear manner reaching
z94% 5 d after serum withdrawal (Fig. 2, a and b). By
contrast, 24 h after mitogen withdrawal, the number of dif-
ferentiated myocytes in MyoD2/2 cultures remained be-
low the limit of detection (Fig. 2, a and b). The number of
differentiated MyoD2/2 myocytes began to accumulate
after 3 d and reached z70% 5 d after serum withdrawal
(Fig. 2, a and b).
Enumeration of differentiated myocytes containing two
or more nuclei in these cultures (i.e., fusion index) re-
vealed a marked reduction in fusion capacity in MyoD2/2
cultures (Fig. 2 c). The fusion index of differentiated wild-
type cultures was z90% 5 d of differentiation with an
average of 4.6 6 0.3 nuclei per myocyte. By contrast, by
day 5 only about 15% of MyoD2/2 myocytes contained
2 nuclei, with an average of 1.2 6 0.2 nuclei per myocyte
(Fig. 2, a and c).
The rate of cell-cycle withdrawal after induction of dif-
ferentiation was assessed by measuring [3H]thymidine in-
corporation at daily intervals after transfer into differenti-
ation medium (Fig. 3 a). In growth medium, [3H]thymidine
labeling experiments revealed that MyoD2/2 cells ex-
hibited an apparent twofold higher growth rate than
wild-type cells (Fig. 3 a). Direct cell count experiments
in growth medium revealed that numbers of primary
MyoD2/2 cells accumulated z1.5-fold faster than wild-
type cells (not shown). Moreover, MyoD2/2 cells dis-
played a 1.6-fold increase in mitotic index as determined
by BrdU incorporation (Fig. 3 b). However, this increase
in apparent growth can be partly accounted for by the re-
duced rate of spontaneous differentiation of mutant (0.10 6
0.14%) versus wild-type cells (10.0 6 1.4%) (see day 0,
Fig. 2, a and b). In addition, interpretation of these results
is also confounded by other potential variables: differ-
ences in the proportion of cells temporarily withdrawn
from the cell-cycle, differences in rates of apoptosis, and
differences in cell-cycle kinetics. Therefore, additional
Figure 2. Reduced differentiation po-
tential of MyoD2/2 myogenic cells.
(a) Differentiated myocytes were de-
tected by immunostaining with anti-
body MF20 reactive with MHC. Incu-
bation of wild-type (WT) myoblast
cultures in differentiation medium re-
sulted in a rapid increase in MHC syn-
thesis and formation of elongated
multinucleated myotubes. By contrast
MyoD-deficient cells (MyoD2/2) dif-
ferentiated with reduced kinetics and
failed to form multinucleated elon-
gated myotubes. Note the 100-fold re-
duced rate of spontaneous differentia-
tion observed in MyoD2/2 cultures
under growth conditions (day 0). Days
correspond to the time spent in differ-
entiation medium before staining,
whereas day 0 represents cultures in
growth medium. (b) Percent MF20
positive cells was determined by enu-
meration of MHC expressing differen-
tiated myocytes by immunostaining
with antibody MF20. Note the delayed
and reduced kinetics of differentiation
in the absence of MyoD. (c) Calcula-
tion of fusion indices as percent cells
containing two or more nuclei within a
differentiated myocyte confirmed that
MyoD2/2 myoblasts were severely
deficient in fusion capacity with the
majority of differentiated myocytes
containing a single nuclei. The error
bars represent the standard error of
the mean from three independently de-
rived primary cultures.Sabourin et al. Differentiation-deficit in MyoD-mutant Myogenic Cells 635
analyses are required to determine whether primary
MyoD2/2 myogenic cells exhibit altered cell-cycle kinet-
ics relative to primary wild-type myoblasts.
Wild-type myoblasts and MyoD2/2 myogenic cells
both exhibited about a twofold increase in the rate of
[3H]thymidine incorporation 24 h after mitogen with-
drawal (Fig. 3 a). This apparent increase in DNA synthesis
may reflect a characteristic of primary cells analogous to
the transient increase in cell proliferation observed after
the IGF-I treatment of myoblasts under culture conditions
that induce differentiation (Engert et al., 1996). After the
first day of mitogen withdrawal, wild-type myoblasts ex-
hibit a rapid withdrawal from the cell cycle as evidenced
by the low levels of [3H]thymidine incorporation (Fig. 3 a).
By contrast, the rate that MyoD2/2 myogenic cells incor-
porated [3H]thymidine continued to increase during the 5 d
after transfer into differentiation medium. Similar results
were obtained using three independent preparations of
low passage primary myogenic cultures.
Taken together, these experiments suggested that
MyoD2/2 myogenic cells displayed continued prolifera-
tion under conditions of low mitogens that normally in-
duce cell-cycle withdrawal and terminal differentiation of
wild-type myoblasts. To investigate cell proliferation un-
der conditions of growth and differentiation, cultured cells
were exposed to BrdU for 4 h followed by immuno-
detection of nuclear localized BrdU incorporated during
DNA synthesis (Fig. 3 b). Wild-type primary myoblasts in
growth medium exhibited a 20% rate of BrdU incorpora-
tion, whereas MyoD2/2 myogenic cells exhibited a 32%
rate of labeling. After 5 d of differentiation, 93% of nuclei
in wild-type cultures expressed MHC and 5.5% were la-
beled by BrdU. In contrast, after 5 d of differentiation,
49% of cells in MyoD2/2 cultures expressed MHC and
17% were labeled by BrdU (see Fig. 2 b). Interestingly,
subconfluent cultures of MyoD2/2 cells in differentiation
medium exhibited up to 20% rates of BrdU incorporation,
whereas confluent cultures exhibited as low as 5% BrdU
labeling (not shown).
Considered together, these data indicate that MyoD2/2
myogenic cells continue to proliferate under low-mitogen
conditions that normally induce terminal differentiation of
wild-type myoblasts and suggest that MyoD2/2 cells ex-
hibit contact inhibition of growth during differentiation.
The observation that MyoD2/2 cells exhibit an enhanced
proliferative potential under conditions that normally in-
duce differentiation strongly supports the notion that
MyoD2/2 myogenic cells exhibit an increased propensity
for self-renewal rather than progression through the dif-
ferentiation program.
Analysis of Muscle-specific Gene Expression
To gain further insight into the differentiation defect in
MyoD2/2 primary cultures, total RNA was prepared
from both wild-type and MyoD2/2 cultures in growth
medium and at daily intervals after induction of differenti-
ation. Northern blot analysis was performed using a panel
of muscle-specific probes.
The expression of the MRFs was investigated to eluci-
date the regulatory relationships and the potential for
functional compensation in the absence of MyoD. North-
ern analysis of the expression pattern of the four MRFs
confirmed that MyoD was expressed at high levels in wild-
type myoblasts and was absent in the MyoD-deficient
myogenic cells. Furthermore, densitometric analysis and
normalization to 18S rRNA revealed that MyoD was
somewhat downregulated during the differentiation of
wild-type cells (Fig. 4 a). Previously, we observed a 3.5-
fold increase in Myf-5 mRNA in newborn and adult mus-
cles in vivo (Rudnicki et al., 1993). We similarly observed
a fourfold increase in Myf-5 mRNA in growing MyoD2/2
myogenic cells relative to wild-type myoblasts, supporting
the hypothesis that MyoD negatively regulates Myf-5 ex-
pression (Fig. 4 b). In wild-type cells, Myf-5 mRNA levels
decreased about twofold after differentiation, whereas in
MyoD2/2 cultures, Myf-5 mRNA levels were upregu-
Figure 3. Enhanced proliferative potential of primary MyoD2/2
myogenic cells in growth and differentiation. (a) Analysis of
[3H]thymidine incorporation during differentiation revealed that
MyoD2/2 myogenic cells continued to synthesize DNA after
mitogen withdrawal. Incorporation was normalized to protein
concentration. The error bars represent the standard error of the
mean for three different isolates. (b) Immunodetection of BrdU
incorporation in MyoD2/2 cultures revealed continued DNA
synthesis after mitogen withdrawal. Differentiation was assessed
by immunostaining with antibody MF20. Taken together, these
data indicate that MyoD2/2 myogenic cells inefficiently with-
draw from the cell cycle under differentiation promoting condi-
tions.The Journal of Cell Biology, Volume 144, 1999 636
lated about twofold after mitogen withdrawal (Fig. 4 b). In
addition, consistent with the observed 100-fold reduction
in the rate of spontaneous differentiation, MyoD2/2
myogenic cells expressed fivefold lower levels of myogenin
mRNA in growth medium relative to wild-type myoblasts
(Fig. 4 c). After the induction of differentiation, the rela-
tive levels of myogenin mRNA in MyoD2/2 cells re-
mained significantly reduced relative to wild-type cultures
(Fig. 4 c). In wild-type cells, the level of MRF4 mRNA
remained unchanged until day 2 of differentiation and
was thereafter upregulated about sevenfold. By contrast,
MRF4 mRNA was upregulated in differentiating MyoD2/2
cultures to levels approximately two- to threefold lower
than that of wild-type cells (Fig. 4 d).
Western analysis of MRF expression in lysates of pri-
mary cultures in growth medium confirmed the absence of
MyoD protein in MyoD2/2 cells (Fig. 4 e). Interestingly,
Myf-5 protein was upregulated .10-fold in MyoD2/2
cells, suggesting that posttranscriptional mechanisms may
contribute to this increase (see Fig. 4, b and e for compari-
son). As suggested by the Northern analysis (Fig. 4 c),
myogenin protein was absent in MyoD2/2 cells in growth
medium, whereas low levels were detected in wild-type
myoblasts (Fig. 4 e).
To assess the differentiation kinetics at the level of gene
expression, Northern analysis was performed with a panel
of muscle-specific markers. Analysis of mRNA levels for
differentiation-specific markers revealed a pattern consis-
Figure 4. Upregulation of Myf-5 and delayed expression of my-
ogenin and MRF4 in MyoD2/2 myogenic cells. Northern analysis
revealed an absence of MyoD mRNA (a) in MyoD2/2 cells (2/2),
and a fourfold upregulation of Myf-5 mRNA (b) relative to wild-
type myoblasts (WT). Upon differentiation, myogenin expression
was upregulated and reduced (c). Similarly, MRF4 expression
was delayed about 1 d in MyoD2/2 cultures after transfer to dif-
ferentiation medium (d). Day 0 denotes samples isolated from
cells in growth medium. RNA samples were prepared 1, 2, 3, 4,
and 5 d after the transfer of the cells to differentiation medium
(DM). The fold activation in arbitrary units for each mRNA spe-
cies is shown graphically beside each Northern blot. Fold activa-
tion was measured by densitometry and was normalized to 18S
rRNA. (e) Western analysis of lysates prepared from wild-type
or MyoD2/2 cultures in growth medium with antiÐMyf-5, anti-
MyoD, and antimyogenin antibodies.
Figure 5. Reduced expression of differentiation-specific markers
in MyoD2/2 myogenic cells. Northern analysis of a-skeletal (a)
and a-cardiac actin (b) mRNA levels revealed reduced and de-
layed kinetics of induction upon differentiation of MyoD2/2
cultures. Similarly, acetylcholine receptor d subunit (AchR d) (c)
and M-cadherin mRNA levels were found to be reduced (d). A
marked reduction in the expression of Musk (e) and adhalin (f)
mRNAs was also observed. The numbered arrows for Musk cor-
respond to the specific isoforms quantitated on the associated
graphs. The fold activation in arbitrary units for each mRNA spe-
cies is shown graphically beside each Northern blot. Fold activa-
tion was measured by densitometry and was normalized to 18S
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tent with overall delayed kinetics of differentiation in
MyoD2/2 myogenic cells. For example, low levels of
a-skeletal and a-cardiac actin mRNAs were detected in
wild-type cells in growth medium and these increased rap-
idly after mitogen withdrawal. By contrast, MyoD2/2
cells in growth medium expressed no detectable sarco-
meric actin mRNA (Fig. 5, a and b). After induction of
differentiation a-skeletal actin mRNA increased about
threefold in wild-type cells, whereas in MyoD2/2 cells the
levels increased z65% of wild-type levels by day 5 (Fig. 5
a). Although lower than that of a-skeletal actin, the levels
of a-cardiac actin were found to increase in a similar pat-
tern (Fig. 5 b). Cultured MyoD2/2 myogenic cells dis-
played a twofold reduction in levels of acetylcholine re-
ceptor d subunit (AchR d) mRNA in growth medium.
After the induction of differentiation, a 5-fold increase
was observed in wild-type cultures compared to an z2-
fold increase in MyoD2/2 cells (Fig. 5 c) for a net 10-fold
relative difference.
The protein coding for M-cadherin, a muscle-specific
adhesion molecule, has been suggested to be expressed in
quiescent satellite cells as well as to play an important role
during myoblast differentiation and fusion (Irintchev et al.,
1994; Pouliot et al., 1994; Zeschnigk et al., 1995). How-
ever, RT-PCR analysis only detects M-cadherin expres-
sion in a small number of quiescent satellite cells suggest-
ing that M-cadherin may not be useful as a marker for
satellite cells (Cornelison and Wold, 1997). In wild-type
cells, M-cadherin mRNA was detected at low levels in
growth medium, M-cadherin increased fivefold by day 2 of
differentiation, and was subsequently downregulated (Fig.
5 d). By contrast, MyoD2/2 myogenic cells in growth me-
dium expressed no detectable M-cadherin mRNA. How-
ever, low levels were detectable after mitogen withdrawal.
Immunohistochemical detection of M-cadherin on cells in
growth medium confirmed the reduced level of protein de-
tectable on MyoD2/2 cells relative to wild-type myo-
blasts (Fig. 1 d). The reduced levels of M-cadherin expres-
sion observed in MyoD2/2 myogenic cells may account in
part for the differentiation deficiency as M-cadherin ap-
pears to be required for efficient myogenic differentiation
and fusion (Zeschnigk et al., 1995).
The receptor tyrosine kinase Musk has been suggested
to be expressed in activated satellite cells (DeChiara et al.,
1996), and therefore may provide an additonal marker for
early myogenic cells. Northern blot analysis with a Musk-
specific probe revealed the expression of three distinct
isoforms in differentiating myogenic cells (Fig. 6 a). In
wild-type cultures in growth medium, the large mRNA
(isoform 1) was not expressed, the midsize mRNA (iso-
form 2) was expressed at intermediate levels, and the small
mRNA (isoform 3) was expressed at higher levels. Induc-
tion of differentiation of wild-type cultures resulted in up-
regulation of isoforms 1 and 2, but little change in isoform
3. By contrast, MyoD2/2 myogenic cells in growth me-
dium expressed no detectable expression of Musk mRNA
isoforms 1 and 2, and low levels of isoform 3. After induc-
tion of differentiation of MyoD2/2 cultures, delayed up-
regulation of isoforms 1 and 2 was observed. Therefore,
these data suggest that Musk is upregulated in a differenti-
ation-dependent manner during muscle regeneration.
Adhalin, a dystrophin-associated protein also known as
Figure 6. Northern analysis of growth-associated gene products.
(a) Primary wild-type myoblasts expressed abundant b-catenin
under growth conditions. These levels increased threefold after 2 d
of differentiation and subsequently decreased. In MyoD2/2 cul-
tures, b-catenin levels were found to continuously increase to lev-
els that were comparable to that of wild-type cells by day 5 of dif-
ferentiation. (b) Wild-type myoblasts during growth expressed
very low levels of PEA3 mRNA, and these levels increased about
twofold by day 5 of differentiation. Growing MyoD2/2 cells dis-
played sixfold higher levels of PEA3 mRNA, which declined
steadily to wild-type levels by day 4 of differentiation. (c) No sig-
nificant differences were observed in p21 mRNA levels between
wild-type and MyoD2/2 cells. (d) Wild-type myoblasts in
growth conditions expressed low levels of IGF-I mRNA and
these levels were rapidly extinguished after mitogen withdrawal.
Mutant  MyoD2/2 myogenic cells expressed over threefold
higher levels of the small IGF-I mRNA isoforms (1 and 2) and
the 7-kb pre-IGF-I mRNA (isoform 3) was rapidly upregulated
after 3 d of differentiation. The numbered arrows adjacent to
IGF-I denote specific isoforms depicted on the corresponding
graph. (e) Expression levels as determined by densitometry were
normalized to 18S rRNA. Differentiation and graphical repre-
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a-sarcoglycan, is upregulated during myoblast differentia-
tion and is required for fully functional myofibers (Ro-
berds et al., 1994; Liu et al., 1997). Human loss-of-function
mutations in adhalin results in limb girdle childhood auto-
somal recessive muscular dystrophy (SCARMD) (Ro-
berds et al., 1994). The delayed differentiation in the limb
girdles evident in MyoD2/2 embryos (Kablar et al., 1997)
raised the possibility that adhalin may represent a MyoD
target gene. Northern analysis revealed that adhalin is
completely absent in growing MyoD2/2 cells (Fig. 5 f).
At the onset of differentiation, adhalin was slightly down-
regulated in wild-type cells, whereas it steadily increased
in MyoD2/2 cultures reaching z50% of wild-type levels
(Fig. 6 b). Therefore, these data substantiate the delayed
differentiation of MyoD2/2 myocytes, but do not eluci-
date whether adhalin is specifically upregulated in the
MyoD-induced embryonic lineage that gives rise to hypax-
ial musculature.
Analysis of Growth-associated Gene Products
To investigate the continued proliferation of MyoD2/2
cells in differentiation medium, we examined the mRNA
expression levels of several growth-associated proteins
that have been demonstrated to play important roles in
the control of myoblast differentiation. The plakoglobin-
related protein, b-catenin (Butz et al., 1992), is believed to
play important roles in cellular growth and morphogenesis
in response to cellular adhesion and Wnt signaling (Miller
and Moon, 1996; Barth et al., 1997). Primary wild-type
myoblasts expressed abundant b-catenin mRNA under
growth conditions. These levels increased threefold after
2 d of differentiation but subsequently decreased (Fig. 6
a). In MyoD2/2 cultures, b-catenin mRNA levels were
found to continuously increase and to stabilize at levels
that were comparable to that of wild-type cells by day 5 of
differentiation (Fig. 6 a). Detection of b-catenin protein
by immunofluorescence revealed a similar nuclear cyto-
plasmic distribution in wild-type and mutant myogenic
cells (Fig. 1 c). Therefore, these data do not support a role
for b-catenin in the differentiation deficiency evident in
MyoD2/2 myogenic cells.
The PEA3 gene product is upregulated in activated sat-
ellite cells in vivo, and has been suggested to be important
for myoblast fusion in vitro (Taylor et al., 1997). Wild-type
primary myoblasts in growth medium expressed very low
levels of PEA3 mRNA. However PEA3 levels increased
about twofold by day 5 of differentiation (Fig. 6 b). By
contrast, MyoD2/2 cells in growth medium displayed
sixfold higher levels of PEA3 mRNA, which declined
steadily to wild-type levels by day 4 of differentiation (Fig.
6 b). However, this increased level of PEA3 was not asso-
ciated with enhanced differentiation (see above). Never-
theless, because PEA3 is expressed in activated satellite
cells (Taylor et al., 1997), these data are consistent with
the notion that primary MyoD2/2 myogenic cells repre-
sent an intermediate stage between a satellite cell and a
myogenic precursor cell.
The p53-inducible cyclin-dependent kinase inhibitor p21/
WAF1 arrests proliferating cells when ectopically ex-
pressed (el-Deiry et al., 1993; Harper et al., 1993) and is
upregulated by MyoD during the differentiation of C2C12
myocytes (Guo et al., 1995; Halevy et al., 1995). Moreover,
forced overexpression of p21 in myoblasts drives induction
of differentiation-specific genes (Skapek et al., 1995). Un-
expectedly, we observed no significant differences in p21
mRNA levels between wild-type and MyoD2/2 cells, in
growth medium or during differentiation (Fig. 6 c). There-
fore, the normal induction of p21 in MyoD2/2 myogenic
cells after mitogen withdrawal suggests that p21 induction
is not MyoD-dependent and that p21 requires MyoD to
positively stimulate differentiation.
The insulin-like growth factor, IGF-I, stimulates the
proliferation and inhibits differentiation of cultured myo-
blasts (Quinn and Roh, 1993; Ewton et al., 1994; Engert et al.,
1996). To assess whether IGF-I expression was altered in
the absence of MyoD, we analyzed expression levels in
primary myogenic cultures. Wild-type myoblasts in growth
conditions expressed low levels of IGF-I mRNA and these
levels were rapidly extinguished after mitogen withdrawal
(Fig. 6 d). By contrast, MyoD2/2 myogenic cells ex-
pressed over threefold higher levels of the small IGF-I
mRNA isoforms 1 and 2 (Yamori et al., 1991) and these
remained constant after transfer of the cells to differentia-
tion medium (Fig. 6 d). Interestingly, the 7-kb pre-IGF-I
mRNA (isoform 3) was not expressed under growth con-
ditions but was rapidly upregulated after 3 d of differentia-
tion. These observations strongly suggest that MyoD nega-
tively regulates IGF-I expression and raises the possibility
that MyoD is required for the repression of IGF-I expres-
sion during normal myogenic differentiation.
The MyoD Mutant Cellular Phenotype Is a Cell 
Autonomous Deficit
The reduced fusion and continued proliferation of MyoD2/2
myogenic cells under conditions that normally promote
cell-cycle withdrawal and terminal differentiation can be
hypothesized to be a consequence of cell autonomous at-
tributes. For example, the marked reduction in M-cad-
herin expression (Figs. 1 d and 6 b) and the overexpression
of IGF-I (Fig. 6 d) in MyoD2/2 myogenic cells could both
act to inhibit differentiation. Alternatively, MyoD2/2 cells
may have a unique developmental identity that precludes
participation in the myogenic precursor cell differentiation
program. To explore these possibilities, we mixed differ-
ent proportions of wild-type myoblasts with lacZ-express-
ing MyoD2/2 myogenic cells, and induced differentiation
by culturing the cells in 5% horse serum for 5 d (Fig. 7).
Importantly, PGK-lacZ expression is unaffected by termi-
nal differentiation in transfected wild-type myoblasts (not
shown). Strikingly, lacZ-labeled nuclei were never de-
tected within any myotubes containing more than two
nuclei (Fig. 7, b and c). Conversely, the differentiation
of wild-type myocytes was completely unaffected by the
presence of high numbers of MyoD2/2 myogenic cells
(compare Fig. 7, b and c, with Fig. 7 d). Taken together,
these data support the notion that Myf-5 expression may
define a distinct cell identity in the satellite cell develop-
mental program.
Our analysis suggested that in satellite cellÐderived
myogenic cell lineage, important aspects of cytomorphol-
ogy, differentiation, and ultimately fusion of mononuclear
cells into myotubes are highly dependent on MyoD activ-Sabourin et al. Differentiation-deficit in MyoD-mutant Myogenic Cells 639
ity and cannot be substituted for by other MRFs. To deter-
mine whether the observed phenotypic differences be-
tween MyoD2/2 and wild-type primary myogenic cells
were attributable to MyoD, a MyoD-expression plasmid
was introduced into low passage cells and stable pools of
transfectants were analyzed. Western blot analysis indi-
cated that transfected MyoD2/2 cells (termed MyoD1)
expressed the exogenous MyoD protein (Fig. 8 a). By den-
sitometry, the levels were found to be approximately
threefold lower than in wild-type cells but similar to
MyoD levels in C2C12 myoblasts. As expected, untrans-
fected or PGK-Puro transfected MyoD2/2 cells did not
express MyoD protein (Fig. 8 a). In growth medium, pools
of stable MyoD1 cells displayed an almost complete re-
version of the fibroblastlike phenotype and exhibited a
rounded compact cytomorphology similar to wild-type
cells (Fig. 8 b). Transfer of MyoD1 cultures into differen-
tiation medium resulted in increased numbers of MF20-
positive differentiated myocytes that displayed the elon-
gated bipolar multinucleated myotube morphology typical
of wild-type myocytes (Fig. 8 b). After 3 d in low serum
medium, the MyoD1 pools displayed fusion indices that
were comparable to wild-type cultures and approximately
fivefold higher than MyoD2/2 cells (Fig. 8 c). Differenti-
ated MyoD1 myocytes contained 2.5 6 0.4 nuclei on aver-
age, differentiated wild-type myocytes contained 2.7 6 0.1
nuclei on average, and differentiated MyoD2/2 myocytes
contained only single nuclei (Fig. 8 c). Lastly, transfection
of MyoD2/2 cells with a Myf-5 expression plasmid did
not rescue cytomorphology or differentiation potential
(not shown). Taken together, these observations suggest
that expression of MyoD is necessary and sufficient to re-
establish the progression of MyoD2/2 myogenic cells
through the differentiation program.
Discussion
Analysis of muscle regeneration in MyoD2/2 mice led to
the suggestion that MyoD is required for satellite cells to
efficiently give rise to proliferative myogenic precursor
cells (Megeney et al., 1996). To characterize the pheno-
type of MyoD-deficient myoblasts and to gain insight into
the role of MyoD in the activation and differentiation of
satellite cells, an in-depth characterization of MyoD2/2
primary myoblast cultures was undertaken. The establish-
ment and propagation of stable cell lines can potentially
result in aneuploidy as well as the introduction of addi-
tional mutations, which are necessary for immortalization
and continuous proliferation in culture. To avoid such
anomalies, all of our analyses were carried out using newly
established low-passage primary myoblast cultures. Our
characterization of early passage primary cultures re-
ported here differs from the analysis of later passage
MyoD2/2 cultures (.15 doublings) that exhibited de-
creased growth, readily formed multinucleated myotubes,
and grew in an FGF2-independent manner (Megeney et al.,
1996; data not shown). Therefore, these results underscore
the importance of characterizing early passage (,10 dou-
blings) primary cultures before any adaptation to growth
in tissue culture conditions.
Primary  MyoD2/2 myogenic cells exhibited a fibro-
blastlike cytomorphology, and expressed c-met and high
levels of PEA3 and IGF-I, but did not express desmin,
M-cadherin, or Musk. Transfer of primary MyoD2/2 cells
into differentiation medium resulted in formation of re-
duced numbers of mononuclear myocytes and delayed in-
duction of differentiation-specific markers. Mixing experi-
ments revealed that MyoD2/2 cells did not influence the
differentiation of wild-type myocytes and did not fuse with
differentiating myotubes. Forced expression of MyoD res-
cued both the cytomorphology and the differentiation
deficit. Taken together, these data suggest that Myf-5
expressing cells represent an intermediate between a qui-
escent satellite cell and a proliferating myogenic precursor
cell.
Northern blot analysis revealed that MyoD2/2 myo-
genic cells expressed fourfold higher levels of Myf-5 mRNA
and Western analysis revealed an even greater increase in
Myf-5 protein. Similar findings are observed for the in vivo
expression of Myf-5 in the muscle of MyoD-deficient mice
(Rudnicki et al., 1992). Interestingly, delayed muscle dif-
ferentiation has also been reported during limb develop-
ment of MyoD2/2 embryos in which Myf-5 expressing
myogenic processors arrive in the limb but differentiate
with markedly delayed kinetics (Kablar et al., 1997). Em-
bryos lacking MyoD display normal development of trunk
musculature in the body proper, whereas muscle develop-
ment in limb buds and branchial arches is delayed by
z2.5 d. In contrast, embryos lacking Myf-5 display normal
muscle development in limb buds and branchial arches,
but exhibit a marked delay in development of trunk mus-
cles. Although MyoD-mutant embryos exhibit delayed
development of limb musculature, the migration of Pax-
3Ðexpressing cells into the limb buds and subsequent in-
Figure 7. Strict cell autonomy in dif-
ferentiated cocultures of lacZ-express-
ing  MyoD2/2 myogenic cells and
wild-type myoblasts. Primary cells
were plated in ratios of 1:0 (a), 1:4 (b),
4:1 (c), and 0:1 (d) of MyoD2/2 to
wild-type cells. After 5 d of differentia-
tion, cells were fixed, and stained for
b-galactosidase and with antibody
MF20 reactive with MHC. Note the
complete absence of lacZ-labeled nu-
clei in myotubes containing greater
than two nuclei and the normal differ-
entiation of wild-type myotubes.The Journal of Cell Biology, Volume 144, 1999 640
duction of Myf-5 in myogenic precursors occurs normally.
These data, together with the observed regeneration defi-
cit in MyoD2/2 muscle, indicate that MyoD and Myf-5
cannot fully substitute for each other during embryogene-
sis and in satellite cells, and suggest that Myf-5 and MyoD
activate discrete subsets of target genes that differentially
define myogenic cell identity.
Forced expression of MyoD in a variety of cell lines in-
duces growth arrest even in the absence of differentiation
(Olson, 1992). Consistent with this, myogenic cells lacking
MyoD displayed inefficient withdrawal from the cell cycle
in response to low mitogens. However, the cell-cycle in-
hibitor p21 was upregulated to similar levels in wild-type
and MyoD2/2 cells in growth medium and following in-
duction of differentiation. In C2C12 myoblasts, expression
of p21 appears to be directly induced by MyoD upon cell-
cycle arrest and terminal differentiation (Guo et al., 1995;
Halevy et al., 1995; Skapek et al., 1995). Moreover, forced
expression of p21 arrests proliferating cells (el-Deiry et al.,
1993; Harper et al., 1993), and induces the terminal differ-
entiation of C2C12 myoblasts (Skapek et al., 1995). There-
fore, the relationship between cell-cycle control and differ-
entiation appears to be uncoupled in primary MyoD2/2
myogenic cells. Interestingly, depending on context, p21
expression can either arrest cells via inhibiting cdk activity,
or promote cell division by acting as a cdk4/cyclin D1 as-
sembly factor (LaBaer et al., 1997). Future characteriza-
tion of cell cycle control in mutant cells should elucidate
this aspect of the MyoD2/2 myogenic cell phenotype.
The PEA3 transcription factor was observed to be ex-
pressed at about sixfold higher levels in MyoD-deficient
myoblasts under growth conditions. The ETS-domain
transcription factor PEA3 (Xin et al., 1992) is rapidly in-
duced after muscle damage and forced expression of PEA3
stimulates myogenesis in vitro when overexpressed in
satellite cellÐderived cultured myoblasts (Peterson and
Houle, 1997; Taylor et al., 1997). These data led to the sug-
gestion that PEA3 is an important regulator of activated
satellite cell function (Taylor et al., 1997). The lack of cor-
Figure 8. Rescue of the differentiation deficiency of MyoD2/2
myogenic cells by forced expression of MyoD. (a) Western blot
analysis revealed the expression of MyoD protein in wild-type
cells (WT) and no expression in MyoD2/2 cultures or MyoD2/2
cells transfected with a selectable vector alone (PGK-Puro).
However,  MyoD-transfected pools of MyoD2/2 cells (MyoD1)
expressed readily detectable MyoD protein as did C2C12 myo-
blasts. (b) In growth medium, MyoD1 cells exhibited a refractile
compact morphology typical of wild-type primary myoblasts and
distinct from the stellate fibroblastlike morphology of MyoD2/2
cells (growth). MyoD1 cultures exposed to differentiation me-
dium for 3 d exhibited increased numbers of differentiated myo-
cytes as detected with antiserum MF20 reactive with MHC, and
restored formation of elongated bipolar multinucleated myo-
tubes (day 3/MF20). (c) Determination of fusion index indicated
a fivefold increase in the fusion potential of MyoD1 cells relative
to untransfected MyoD2/2 cells and similar to wild-type (WT)
cultures. Fusion indices were calculated as described in Fig. 4.
Figure 9. Role of MyoD in regulating satellite cell function.
RT-PCR analysis of single cells on cultured myofibers reveals
quiescent satellite cells express c-met but no detectable MRFs.
Activated satellite cells first express Myf-5 or MyoD before coex-
pressing both Myf-5 and MyoD, and progressing through their
normal developmental program leading to terminal differentia-
tion (Cornelison and Wold, 1997). In the absence of MyoD, satel-
lite cells appear to exhibit a propensity for self-renewal rather
than progression through the differentiation program (Megeney
et al., 1996). Therefore, expression of Myf-5 alone may allow self-
renewal of satellite cells either before returning to quiescence
(yellow arrows) or upregulating MyoD and formation of prolifer-
ative myogenic precursor cells (mpc) (white arrows). The poten-
tial and replicative capacity of cells expressing MyoD alone is un-
known; however, these cells likely irreversibly progress through
the myogenic program. Taken together, we interpret these data
to suggest that MyoD2/2 myogenic cells represent an intermedi-
ate stage between myogenic stem cell and a myogenic precursor
cell.Sabourin et al. Differentiation-deficit in MyoD-mutant Myogenic Cells 641
relation between increased expression of PEA3 and differ-
entiation potential in MyoD2/2 myogenic cells supports
the assertion that MyoD2/2 myogenic cells have an iden-
tity distinct from wild-type myoblasts. Interestingly, over-
expression of PEA3 is correlated with increased meta-
static potential of mammary adenocarcinomas (Trimble
et al., 1993). Moreover, overexpression of PEA3 in cul-
tured cells directly induces the upregulation of a subset of
matrix metalloproteases (Hassell, J.A., personal commu-
nication). After muscle damage, activated satellite cells
readily cross the basal lamina and are capable of migrating
from surviving to damaged areas (Hughes and Blau, 1990;
Phillips et al., 1990). By contrast, cultured primary myo-
blasts injected into muscle exhibit a very poor ability to
migrate away from the injection site (Fan et al., 1996; Gus-
soni et al., 1997). Therefore, it will be of interest to deter-
mine whether MyoD2/2 cells are more invasive than
their wild-type counterpart.
M-cadherin had been suggested to be expressed in satel-
lite cells (Irintchev et al., 1994). However, recent RT-PCR
analysis indicates that a small minority of satellite cells ex-
press  M-cadherin mRNA (Cornelison and Wold, 1997).
Consistent with this we observed markedly reduced ex-
pression of M-cadherin in MyoD2/2 myogenic cells rela-
tive to wild-type cells (see Figs. 1 d and 5 b). This observa-
tion raises the possibility that MyoD directly or indirectly
regulates the expression of surface adhesion molecules
involved in fusion and differentiation. Interestingly, incu-
bation of antagonistic M-cadherin peptides or antisense
RNA inhibits both myoblast fusion and cell-cycle with-
drawal in conditions that normally promote differentiation
(Zeschnigk et al., 1995). Therefore, these data suggest that
cell-cycle withdrawal during terminal differentiation also
involves cellÐcell interactions.
Cellular adhesion is clearly linked to regulation of pro-
liferation, migration, and differentiation. For example,
expression of dominant negative cadherin inhibits prolif-
eration and stimulates terminal differentiation of human
epidermal keratinocytes (Zhu and Watt, 1996). Moreover,
integrin and cadherin synergistically inhibit migration and
promote the aggregation of myoblasts (Huttenlocher et al.,
1998). Forced overexpression of an effector of adhesion
mediated signaling integrin-linked kinase (ILK) in intesti-
nal epithelial cells and mammary epithelial cells induces
the activity of G1/S cyclin/Cdks, downregulates E-cad-
herin expression, induces nuclear translocation of b-cate-
nin, and results in increased invasiveness (Radeva et al.,
1997; Novak et al., 1998). Therefore, examination of inte-
grin and cadherin function in MyoD2/2 myogenic cells
should elucidate the role of adhesion in the control of pro-
liferation and migration in early myogenic precursors.
High level expression of IGF-I in L6 myoblasts stimu-
lates proliferation and inhibits differentiation, whereas
lower levels of IGF-I stimulate both proliferation and dif-
ferentiation (Quinn and Roh, 1993; Ewton et al., 1994;
Lefaucheur and Sebille, 1995; Engert et al., 1996). A strik-
ing feature of MyoD2/2 cells was the relatively high ex-
pression of IGF-I mRNA and its continued upregulation
during differentiation. In contrast, wild-type myoblasts ex-
pressed lower levels of IGF-I in growth conditions and
these levels decreased during differentiation. It is inter-
esting to speculate that increased IGF-I expression in
MyoD2/2 cultures contributes to the observed differenti-
ation delay. As IGF-I levels rapidly decrease in wild-type
cultures induced to differentiate, an interesting hypothesis
is that MyoD is required to downregulate IGF-I at the on-
set of differentiation. In MyoD2/2 myogenic cells, con-
tinued IGF-I expression could result in an autocrine loop
that acts to promote proliferation. However, the presence
of MyoD2/2 myogenic cells did not inhibit the differenti-
ation of wild-type primary myoblasts raising the possibility
that expression of other components of the IGF-I signal-
ing pathway are downregulated in wild-type myoblasts.
These data further underscore the assertion that MyoD2/2
myogenic cells are distinct from wild-type myoblasts.
Continuous myoblast cell lines lacking MyoD exhibit
somewhat similar traits in comparison to primary MyoD2/2
myogenic cells. For example, C2C12 cells expressing anti-
sense MyoD RNA, display increased Myf-5 expression,
decreased  IGF-II expression, and are defective in differen-
tiation (Montarras et al., 1996). The brain tumorÐderived
BC3H1 myoblast cell line (Taubman et al., 1989) expresses
Myf-5 but does not express MyoD, and exhibits a differen-
tiation deficit with reduced ability to form multinucleated
myotubes (Brennan et al., 1990). However, unlike primary
MyoD-deficient myogenic cells, BC3H1 myocytes in dif-
ferentiation-inducing medium exhibit normal upregula-
tion of myogenin together with normal induction of sub-
sets of MHC isoforms and other differentiation-specific
markers (Taubman et al., 1989; Miller, 1990; Brennan et al.,
1990). Forced expression of myogenin in BC3H1 cells is
unable to rescue the differentiation deficit, whereas forced
expression of MyoD confers competency for myogenic dif-
ferentiation (Brennan et al., 1990). Forced expression of a
functional MyoD protein in MyoD-deficient cells was suf-
ficient to revert the MyoD2/2 cytomorphology and res-
cue the differentiation defect as evidenced by a dramatic
increase in fusion index of MyoD1 cells. Therefore, these
data support the assertion that lack of MyoD results in a
cell-autonomous deficit in the satellite cell differentiation
program. Taken together, the parallels observed between
primary  MyoD2/2 myocytes and continuous myoblast
cell lines deficient in MyoD support a unique set of func-
tions for MyoD that cannot be substituted for by Myf-5.
The muscle regeneration deficit in MyoD2/2 muscle
suggests that expression of MyoD is required for satellite
cells to efficiently form differentiation-competent myo-
genic precursor cells (Megeney et al., 1996). RT-PCR
analysis reveals that activated satellite cells first express ei-
ther  Myf-5 alone or MyoD alone, before coexpressing
Myf-5 and MyoD, and subsequently progressing through
the myogenic program (Cornelison and Wold, 1997). Our
analysis of the phenotype of primary MyoD2/2 myogenic
cells can be interpreted to suggest that MyoD2/2 myo-
genic cells represent an intermediate stage between a qui-
escent satellite cell and a myogenic precursor cell. To-
gether, these data suggest the hypothesis that expression
of Myf-5 alone may define an intermediate developmental
stage that provides a mechanism for satellite cell self-
renewal. In this model, activated satellite cells expressing
only Myf-5 could undergo cell division and either return to
quiescence by downregulating Myf-5, or alternatively up-
regulating MyoD and progressing through the myogenic
program (see Fig. 9). Clearly, further analysis of the devel-The Journal of Cell Biology, Volume 144, 1999 642
opmental potential and phenotype of primary MyoD2/2
myogenic cells may present a unique opportunity to inves-
tigate the early myogenic program of satellite cells.
M.A. Rudnicki is a research scientist of the National Cancer Institute of
Canada, and a member of the Canadian Genetic Disease Network of Ex-
cellence. L.A. Sabourin is a postdoctoral fellow of the Medical Research
Council of Canada, and P. Seale is supported by an National Science and
Engineering Research Scholarship.
This work was supported by grants from the National Institutes of
Health and the Muscular Dystrophy Association to M.A. Rudnicki.
Received for publication 20 July 1998 and in revised form 8 January 1999.
References
Allen, R.E., S.M. Sheehan, R.G. Taylor, T.L. Kendall, and G.M. Rice. 1995.
Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in
vitro. J. Cell. Physiol. 165:307Ð312.
Bader, D., T. Masaki, and D.A. Fischman. 1982. Immunochemical analysis of
myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol.
95:763Ð770.
Barth, A.I., I.S. Nathke, and W.J. Nelson. 1997. Cadherins, catenins and APC
protein: interplay between cytoskeletal complexes and signaling pathways.
Curr. Opin. Cell Biol. 9:683Ð690.
Birnboim, H.C. 1988. Rapid extraction of high molecular weight RNA from
cultured cells and granulocytes for Northern analysis. Nucleic Acids Res. 16:
1487Ð1497.
Bischoff, R. 1994. The satellite cell and muscle regeneration. In Myogenesis.
Vol. 2. A.G. Engel and C. Franszini-Armstrong, editors. McGraw-Hill Inc.,
New York. 97Ð118.
Braun, T., M.A. Rudnicki, H.H. Arnold, and R. Jaenisch. 1992. Targeted inacti-
vation of the muscle regulatory gene Myf-5 results in abnormal rib develop-
ment and perinatal death. Cell. 71:369Ð382.
Brennan, T.J., D.G. Edmondson, and E.N. Olson. 1990. Aberrant regulation of
MyoD1 contributes to the partially defective myogenic phenotype of BC3H1
cells. J. Cell Biol. 110:929Ð937.
Butz, S., J. Stappert, H. Weissig, and R. Kemler. 1992. Plakoglobin and beta-
catenin: distinct but closely related. Science. 257:1142Ð1144.
Cornelison, D.D., and B.J. Wold. 1997. Single-cell analysis of regulatory gene
expression in quiescent and activated mouse skeletal muscle satellite cells.
Dev. Biol. 191:270Ð283.
Cossu, G., P. Cicinelli, C. Fieri, M. Coletta, and M. Molinaro. 1985. Emergence
of TPA-resistant ÒsatelliteÓ cells during muscle histogenesis of human limb.
Exp. Cell Res. 160:403Ð411.
DeChiara, T.M., D.C. Bowen, D.M. Valenzuela, M.V. Simmons, W.T. Pou-
eymirou, S. Thomas, E. Kinetz, D.L. Compton, E. Rojas, J.S. Park, et al.
1996. The receptor tyrosine kinase MuSK is required for neuromuscular
junction formation in vivo. Cell. 85:501Ð512.
el-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent,
D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a po-
tential mediator of p53 tumor suppression. Cell. 75:817Ð825.
Engert, J.C., E.B. Berglund, and N. Rosenthal. 1996. Proliferation precedes dif-
ferentiation in IGF-I-stimulated myogenesis. J. Cell Biol. 135:431Ð440.
Ewton, D.Z., S.L. Roof, K.A. Magri, F.J. McWade, and J.R. Florini. 1994. IGF-
II is more active than IGF-I in stimulating L6A1 myogenesis: greater mito-
genic actions of IGF-I delay differentiation. J. Cell Physiol. 161:277Ð284.
Fan, Y., M. Maley, M. Beilharz, and M. Grounds. 1996. Rapid death of injected
myoblasts in myoblast transfer therapy. Muscle Nerve. 19:853Ð860.
George-Weinstein, M., R.F. Foster, J.V. Gerhart, and S.J. Kaufman. 1993. In
vitro and in vivo expression of alpha 7 integrin and desmin define the pri-
mary and secondary myogenic lineages. Dev. Biol. 156:209Ð229.
Guo, K., J. Wang, V. Andres, R.C. Smith, and K. Walsh. 1995. MyoD-induced
expression of p21 inhibits cyclin-dependent kinase activity upon myocyte
terminal differentiation. Mol. Cell Biol. 15:3823Ð3829.
Gussoni, E., H.M. Blau, and L.M. Kunkel. 1997. The fate of individual myo-
blasts after transplantation into muscles of DMD patients. Nat. Med. 3:970Ð977.
Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D.
Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of
skeletal muscle with induction of p21 by MyoD. Science. 267:1018Ð1021.
Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The
p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-depen-
dent kinases. Cell. 75:805Ð816.
Hughes, S.M., and H.M. Blau. 1990. Migration of myoblasts across basal lamina
during skeletal muscle development. Nature. 345:350Ð353.
Huttenlocher, A., M. Lakonishok, M. Kinder, S. Wu, T. Truong, K.A. Knudsen,
and A.F. Horwitz. 1998. Integrin and cadherin synergy regulates contact in-
hibition of migration and motile activity. J. Cell Biol. 141:515Ð526.
Irintchev, A., M. Zeschnigk, A. Starzinski-Powitz, and A. Wernig. 1994. Ex-
pression pattern of M-cadherin in normal, denervated, and regenerating
mouse muscles. Dev. Dyn. 199:326Ð337.
Kablar, B., K. Krastel, C. Ying, A. Asakura, S.J. Tapscott, and M.A. Rudnicki.
1997. MyoD and Myf-5 differentially regulate the development of limb ver-
sus trunk skeletal muscle. Development (Camb.). 124:4729Ð4738.
LaBaer, J., M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Sandhu, H.S.
Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21
family of CDK inhibitors. Genes Dev. 11:847Ð862.
LeCouter, J.E., P.F. Whyte, and M.A. Rudnicki. 1996. Cloning and expression
of the Rb-related mouse p130 mRNA. Oncogene. 12:1433Ð1440.
Lefaucheur, J.P., and A. Sebille. 1995. Muscle regeneration following injury can
be modified in vivo by immune neutralization of basic fibroblast growth fac-
tor, transforming growth factor beta 1 or insulin-like growth factor I. J. Neu-
roimmunol. 57:85Ð91.
Liu, L., P.H. Vachon, W. Kuang, H. Xu, U.M. Wewer, P. Kylsten, and E. Eng-
vall. 1997. Mouse adhalin: primary structure and expression during late
stages of muscle differentiation in vitro. Biochem. Biophys. Res. Commun.
235:227Ð235.
Maniatis, T., E.F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Labo-
ratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor,
New York. 545 pp.
Megeney, L.A., and M.A. Rudnicki. 1995. Determination versus differentiation
and the MyoD family of transcription factors. Biochem. Cell Biol. 73:723Ð732.
Megeney, L.A., B. Kablar, K. Garrett, J.E. Anderson, and M.A. Rudnicki.
1996. MyoD is required for myogenic stem cell function in adult skeletal
muscle. Genes Dev. 10:1173Ð1183.
Miller, J.B. 1990. Myogenic programs of mouse muscle cell lines: expression of
myosin heavy chain isoforms, MyoD1, and myogenin. J. Cell Biol. 111:1149Ð
1159.
Miller, J.R., and R.T. Moon. 1996. Signal transduction through beta-catenin
and specification of cell fate during embryogenesis. Genes Dev. 10:2527Ð
2539.
Montarras, D., F. Aurade, T. Johnson, J. IIan, F. Gros, and C. Pinset. 1996. Au-
tonomous differentiation in the mouse myogenic cell line, C2, involves a mu-
tual positive control between insulin-like growth factor II and MyoD, oper-
ating as early as at the myoblast stage. J. Cell Sci. 109:551Ð560.
Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, and I. Nonaka.
1993. Myogenin gene disruption results in perinatal lethality because of se-
vere muscle defect. Nature. 364:532Ð535.
Novak, A., S.C. Hsu, C. Leung-Hagesteijn, G. Radeva, J. Papkoff, R. Monte-
sano, C. Roskelley, R. Grosschedl, and S. Dedhar. 1998. Cell adhesion and
the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling
pathways.  Proc. Natl. Acad. Sci. USA. 95:4374Ð4379.
Olson, E.N. 1992. Interplay between proliferation and differentiation within the
myogenic lineage. Dev. Biol. 154:261Ð272.
Patapoutian, A., J.K. Yoon, J.H. Miner, S. Wang, K. Stark, and B. Wold. 1995.
Disruption of the mouse MRF4 gene identifies multiple waves of myogene-
sis in the myotome. Development. 121:3347Ð3358.
Peterson, C.A., and J.D. Houle. 1997. Transcription factor polyomavirus en-
hancer activator protein 3 (PEA3) is induced in adult rats following muscle
injury. J. Nutr. 127(Suppl.):1007Ð1010.
Phillips, G.D., J.R. Hoffman, and D.R. Knighton. 1990. Migration of myogenic
cells in the rat extensor digitorum longus muscle studied with a split au-
tograft model. Cell Tissue Res. 262:81Ð88.
Phi-Van, L., and W.H. Stratling. 1996. Dissection of the ability of the chicken
lysozyme gene 59 matrix attachment region to stimulate transgene expres-
sion and to dampen position effects. Biochemistry. 35:10735Ð10742.
Pouliot, Y., M. Gravel, and P.C. Holland. 1994. Developmental regulation of
M-cadherin in the terminal differentiation of skeletal myoblasts. Dev. Dyn.
200:305Ð312.
Quinn, L.S., and J.S. Roh. 1993. Overexpression of the human type-1 insulin-
like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell
proliferation and inhibition of differentiation. Exp. Cell Res. 208:504Ð508.
Radeva, G., T. Petrocelli, E. Behrend, C. Leung-Hagesteijn, J. Filmus, J. Sling-
erland, and S. Dedhar. 1997. Overexpression of the integrin-linked kinase
promotes anchorage-independent cell cycle progression. J. Biol. Chem. 272:
13937Ð13944.
Roberds, S.L., F. Leturcq, V. Allamand, F. Piccolo, M. Jeanpierre, R.D. Ander-
son, L.E. Lim, J.C. Lee, F.M. Tome, N.B. Romero, et al. 1994. Missense mu-
tations in the adhalin gene linked to autosomal recessive muscular dystro-
phy. Cell. 78:625Ð633.
Rudnicki, M.A., and R. Jaenisch. 1995. The MyoD family of transcription fac-
tors and skeletal myogenesis. Bioessays. 17:203Ð209.
Rudnicki, M.A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of
MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and
results in apparently normal muscle development. Cell. 71:383Ð390.
Rudnicki, M.A., P.N. Schnegelsberg, R.H. Stead, T. Braun, H.H. Arnold, and
R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal
muscle. Cell. 75:1351Ð1359.
Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lassar. 1995. Inhibition of myo-
genic differentiation in proliferating myoblasts by cyclin D1-dependent ki-
nase. Science. 267:1022Ð1024.
Smith, C.K., 2nd, M.J. Janney, and R.E. Allen. 1994. Temporal expression of
myogenic regulatory genes during activation, proliferation, and differentia-
tion of rat skeletal muscle satellite cells. J. Cell Physiol. 159:379Ð385.
Taubman, M.B., C.W. Smith, S. Izumo, J.W. Grant, T. Endo, A. Andreadis, and
B. Nadal-Ginard. 1989. The expression of sarcomeric muscle-specific con-
tractile protein genes in BC3H1 cells: BC3H1 cells resemble skeletal myo-Sabourin et al. Differentiation-deficit in MyoD-mutant Myogenic Cells 643
blasts that are defective for commitment to terminal differentiation. J. Cell
Biol. 108:1799Ð1806.
Taylor, J.M., E.E. Dupont-Versteegden, J.D. Davies, J.A. Hassell, J.D. Houle,
C.M. Gurley, and C.A. Peterson. 1997. A role for the ETS domain transcrip-
tion factor PEA3 in myogenic differentiation. Mol. Cell Biol. 17:5550Ð5558.
Trimble, M.S., J.H. Xin, C.T. Guy, W.J. Muller, and J.A. Hassell. 1993. PEA3 is
overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene.
8:3037Ð3042.
Weintraub, H., R. Davis, S. Tapscott, M. Thayer, M. Krause, R. Benezra, T.K.
Blackwell, D. Turner, R. Rupp, S. Hollenberg, et al. 1991. The myoD gene
family: nodal point during specification of the muscle cell lineage. Science.
251:761Ð766.
Xin, J.H., A. Cowie, P. Lachance, and J.A. Hassell. 1992. Molecular cloning and
characterization of PEA3, a new member of the Ets oncogene family that is
differentially expressed in mouse embryonic cells. Genes Dev. 6:481Ð496.
Yablonka-Reuveni, Z., and A.J. Rivera. 1994. Temporal expression of regula-
tory and structural muscle proteins during myogenesis of satellite cells on
isolated adult rat fibers. Dev. Biol. 164:588Ð603.
Yamori, T., Y. Iizuka, Y. Takayama, S. Nishiya, S. Iwashita, A. Yamazaki, T.
Takatori, and T. Tsuruo. 1991. Insulin-like growth factor I rapidly induces
tyrosine phosphorylation of a Mr 150,000 and a Mr 160,000 protein in highly
metastatic mouse colon carcinoma 26 NL-17 cells. Cancer Res. 51:5859Ð5865.
Zeschnigk, M., D. Kozian, C. Kuch, M. Schmoll, and A. Starzinski-Powitz.
1995. Involvement of M-cadherin in terminal differentiation of skeletal mus-
cle cells. J. Cell Sci. 108:2973Ð2981.
Zhang, W., R.R. Behringer, and E.N. Olson. 1995. Inactivation of the myogenic
bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies.
Genes Dev. 9:1388Ð1399.
Zhu, A.J., and F.M. Watt. 1996. Expression of a dominant negative cadherin
mutant inhibits proliferation and stimulates terminal differentiation of hu-
man epidermal keratinocytes. J. Cell Sci. 109:3013Ð3023.